These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


578 related items for PubMed ID: 19212119

  • 21. Hepatic resection for malignant melanoma.
    Crook TB, Jones OM, John TG, Rees M.
    Eur J Surg Oncol; 2006 Apr; 32(3):315-7. PubMed ID: 16364589
    [Abstract] [Full Text] [Related]

  • 22. New concepts in the therapeutic options of liver metastases from colorectal cancer.
    Andromanakos N, Filippou D, Papadopoulos V, Kouraklis G, Christianakis E, Kostakis A.
    J BUON; 2007 Apr; 12(4):445-52. PubMed ID: 18067201
    [Abstract] [Full Text] [Related]

  • 23. Review article: Multimodality treatment of liver metastases increases suitability for surgical treatment.
    de Jong KP.
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():161-9. PubMed ID: 18081659
    [Abstract] [Full Text] [Related]

  • 24. Surgical treatment of metastatic melanoma confined to the liver.
    Papachristou DN, Fortner JJ.
    Int Surg; 1983 Dec; 68(2):145-8. PubMed ID: 6885293
    [Abstract] [Full Text] [Related]

  • 25. [The therapy of the liver metastases of colorectal carcinoma].
    Spagliardi E, Torelli P, Barra M, Orsi D, Bruzzo F.
    Minerva Chir; 1994 Oct; 49(10 Suppl 1):51-5. PubMed ID: 7700555
    [Abstract] [Full Text] [Related]

  • 26. Stop-flow perfusion with mitomycin-C as locoregional approach in the treatment of large-unresectable liver metastases.
    Gadaleta C, Catino A, Mattioli V.
    In Vivo; 2006 Oct; 20(6A):769-71. PubMed ID: 17203765
    [Abstract] [Full Text] [Related]

  • 27. Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma.
    Caralt M, Martí J, Cortés J, Fondevila C, Bilbao I, Fuster J, García-Valdecasas JC, Sapisochín G, Balsells J, Charco R.
    J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):268-75. PubMed ID: 21057964
    [Abstract] [Full Text] [Related]

  • 28. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
    Alexander HR, Libutti SK, Pingpank JF, Steinberg SM, Bartlett DL, Helsabeck C, Beresneva T.
    Clin Cancer Res; 2003 Dec 15; 9(17):6343-9. PubMed ID: 14695133
    [Abstract] [Full Text] [Related]

  • 29. Liver resection for metastatic melanoma: equivalent survival for cutaneous and ocular primaries.
    Ryu SW, Saw R, Scolyer RA, Crawford M, Thompson JF, Sandroussi C.
    J Surg Oncol; 2013 Aug 15; 108(2):129-35. PubMed ID: 23813600
    [Abstract] [Full Text] [Related]

  • 30. Modern multimodality approach to hepatic colorectal metastases: solutions and controversies.
    Khatri VP, Chee KG, Petrelli NJ.
    Surg Oncol; 2007 Jul 15; 16(1):71-83. PubMed ID: 17532622
    [Abstract] [Full Text] [Related]

  • 31. An update and our experience with metastatic liver disease.
    Koshariya M, Jagad RB, Kawamoto J, Papastratis P, Kefalourous H, Porfiris T, Tzouma C, Lygidakis NJ.
    Hepatogastroenterology; 2007 Dec 15; 54(80):2232-9. PubMed ID: 18265640
    [Abstract] [Full Text] [Related]

  • 32. [Therapeutic protocols in the treatment of liver metastases].
    Boese-Landgraf J, Häring R, Berger G, Gallkowski U.
    Zentralbl Chir; 1991 Dec 15; 116(7):439-46. PubMed ID: 1711746
    [Abstract] [Full Text] [Related]

  • 33. Prolonged survival after complete resection of metastases from intraocular melanoma.
    Rivoire M, Kodjikian L, Négrier S.
    Cancer; 2004 Jul 01; 101(1):207-8; author reply 208. PubMed ID: 15222009
    [No Abstract] [Full Text] [Related]

  • 34. [Timing of resection in patients with colorectal carcinoma and synchronous liver metastases].
    Hopt UT, Drognitz O, Neeff H.
    Zentralbl Chir; 2009 Sep 01; 134(5):425-9. PubMed ID: 19757342
    [Abstract] [Full Text] [Related]

  • 35. [Study and treatment of locally advanced melanoma].
    Moreno-Ramírez D, de la Cruz L, Ferrándiz L, Camacho FM.
    Actas Dermosifiliogr; 2009 Nov 01; 100(9):767-79. PubMed ID: 19889298
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
    Mulier S, Ruers T, Jamart J, Michel L, Marchal G, Ni Y.
    Dig Surg; 2008 Nov 01; 25(6):445-60. PubMed ID: 19212117
    [Abstract] [Full Text] [Related]

  • 38. [The latest diagnostical methods and therapy in melanoma].
    Wojas-Pelc A, Rajzer L, Jaworek A, Woźniak W.
    Przegl Lek; 2006 Nov 01; 63(8):674-80. PubMed ID: 17441381
    [Abstract] [Full Text] [Related]

  • 39. Development of isolated hepatic perfusion via the operative and percutaneous techniques for patients with isolated and unresectable liver metastases.
    Alexander HR, Butler CC.
    Cancer J; 2010 Nov 01; 16(2):132-41. PubMed ID: 20404610
    [Abstract] [Full Text] [Related]

  • 40. Diagnosis and treatment of metastatic disease to the liver.
    Arciero CA, Sigurdson ER.
    Semin Oncol; 2008 Apr 01; 35(2):147-59. PubMed ID: 18396200
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.